Medical Oncology

Dermatomyositis

Questions discussed in this category

What is your approach to screening for malignancy in dermatomyositis patients who do not have a high risk antibody profile and whose disease responds well to treatment?

Do you pursue screening beyond age-appropriate malignancy screening, especially in younger patients? For how long do you continue to monitor beyond th...

1 Answer available

What is the recommended approach for systemic therapy in a patient with metastatic cutaneous squamous cell carcinoma with active autoimmune disease (dermatomyositis)?

2 Answers available

Do you offer adjuvant radiation therapy for a breast cancer patient with dermatomyositis?

If so, what dose-fractionation do you utilize? What other factors do you take into consideration?

2 Answers available

Papers discussed in this category

Nature reviews. Rheumatology, 2023 Nov 09

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

Cancer cell, 2022 May 09

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.

Medical Oncology

Dermatomyositis

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology